Letter Sequence Other |
|---|
|
Initiation
- Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request
- Acceptance
Results
Other: ML15210A112, ML15210A117, ML15210A120, ML15210A122, ML15210A124, ML15271A005, ML15271A014, ML16033A179, ML16033A180, ML16344A054, ML16344A055
|
MONTHYEARML15210A1202015-07-20020 July 2015
Attachment 3 - Northwest Medical Isotopes, LLC - Part Two, Construction Permit Application, Chapter 5 Through Chapter 8
Project stage: Other
ML15210A1172015-07-20020 July 2015
Attachment 3 - Northwest Medical Isotopes, LLC - Part Two, Construction Permit Application, Chapter 3 Through Chapter 4
Project stage: Other
ML15210A1242015-07-20020 July 2015
Attachment 3 - Northwest Medical Isotopes, LLC - Part Two, Construction Permit Application, Chapter 13, Part 1 of 2
Project stage: Other
ML15210A1122015-07-20020 July 2015
Attachment 3 - Northwest Medical Isotopes, LLC - Part Two, Construction Permit Application, General Information Per 10 CFR 50.33, Filing Free Required by 10 CFR 50.30(e) and 10 CFR 170.21, Classified Information Agreement Per 10 CFR 50.37,
Project stage: Other
ML15210A1222015-07-20020 July 2015
Attachment 3 - Northwest Medical Isotopes, LLC - Part Two, Construction Permit Application, Chapter 13, Part 2 of 2
Project stage: Other
ML15210A1142015-07-20020 July 2015
NRC Project No. 0803 - Northwest Medical Isotopes, LLC, Submittal of Part 2 Construction Permit Application for a Radioisotope Production Facility
Project stage: Request
ML16344A0552015-08-29029 August 2015
NWMI-2015-CSE-008, Nwmi Preliminary Criticality Safety Evaluation: Hot Cell Uranium Purification (Recovery and Recycle) (Rev. a) (Public Version)
Project stage: Other
ML15271A0052015-10-28028 October 2015
FRN - Northwest Medical Isotopes, LLC, Construction Permit Application Part Two: Acknowledgement of Receipt and Availability
Project stage: Other
ML15271A0142015-11-0505 November 2015
Northwest Medical Isotopes, LLC - Acknowledgement of Receipt and Availability, Application for Construction Permit Part Two - Letter
Project stage: Other
ML15348A0212015-12-24024 December 2015
FRN - Northwest Medical Isotopes, LLC - Acceptance for Docketing of Part Two of the Application for a Production Facility Construction Permit
Project stage: Acceptance Review
ML16048A5542016-02-17017 February 2016
Rev 9 Mo-99 Overview and Status Slides No Notes
Project stage: Request
ML16083A1062016-02-18018 February 2016
Transcript of Public Meeting with Northwest Medical Isotopes on February 18, 2016, Pages 1-176
Project stage: Request
ML16056A1222016-03-28028 March 2016
Northwest Medical Isotopes LLC - Request for Additional Information Regarding Application for Construction Permit (MF6135 and MF6138)
Project stage: RAI
ML16083A1072016-03-29029 March 2016
February 18, 2016 Summary of Public Meeting with Northwest Medical Isotopes
Project stage: Meeting
ML16123A1192016-04-25025 April 2016
Northwest Medical Isotopes, LLC - Responses to the NRC Environmental Request for Additional Information - Letter Dated March 28, 2016
Project stage: Request
ML16033A1792016-05-18018 May 2016
FRN Northwest Medical Isotopes LLC - Notice of Hearing, Opportunity to Petition for Leave to Intervene, and Order Imposing Procedures Regarding Application for Construction Permit
Project stage: Other
ML16033A1802016-05-24024 May 2016
Letter to Northwest Medical Isotopes LLC - Notice of Hearing, Opportunity to Petition for Leave to Intervene, and Order Imposing Procedures Regarding Application for Construction Permit
Project stage: Other
ML16216A1862016-06-0202 June 2016
University of Missouri-Columbia Research Reactor - Mo-99 Presentation (Public)
Project stage: Request
ML16210A3052016-07-18018 July 2016
Northwest Medical Isotopes, LLC, Response to Request for Additional Information Regarding Chapters 4, 13, and 19 of the Preliminary Safety Analysis Report and Environmental Review
Project stage: Response to RAI
ML16270A3772016-09-0101 September 2016
Northwest Medical Isotopes, LLC, Response to Environmental Request for Additional Information - Additional Clarification on POSA3-1A, POSA3-2A, POSA3-3A, NOI3-IB, and PA3-1
Project stage: Request
ML16236A0132016-09-29029 September 2016
Northwest Medical Isotopes, LLC - Request for Additional Information Regarding Application for Construction Permit
Project stage: RAI
ML16288A4882016-10-20020 October 2016
Summary of Public Meeting with Northwest Medical Isotopes, LLC
Project stage: Meeting
ML16344A0542016-11-28028 November 2016
NWMl-2014-RPT-006, Northwest Medical Isotopes, LLC - MCNP 6.1 Validations with Continuous Energy ENDF/B-VII.1 Cross-Sections (Rev. 0) (Public Version)
Project stage: Other
ML16344A0522016-11-28028 November 2016
Northwest Medical Isotopes, LLC - Responses to the U.S. Nuclear Regulatory Commission Regarding the Preliminary Safety Analysis Report Request for Additional Information
Project stage: Request
ML16344A0532016-11-28028 November 2016
Northwest Medical Isotopes, LLC - Response to the U.S. Nuclear Regulatory Commission Request for Additional Information Regarding the Preliminary Safety Analysis Report and Environmental Review
Project stage: Request
ML17093A6612017-03-0606 March 2017
Northwest Medical Isotopes, LLC Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated January 25, 2017
Project stage: Request
ML17069A4082017-03-29029 March 2017
Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit
Project stage: RAI
ML17128A0662017-04-28028 April 2017
Northwest Medical Isotopes, LLC Response to the NRC Regarding the Request for Additional Information Regarding Application for Construction Permit (Letter Dated March 29, 2017)
Project stage: Request
ML17128A0672017-04-28028 April 2017
NWMI-2017-RAI-002, Rev. 0, Response to the U.S. Nuclear Regulatory Commission Northwest Medical Isotopes, LLC - Request for Additional Information Regarding Application for Construction Permit
Project stage: Request
ML17157B4112017-06-0202 June 2017
Northwest Medical Isotopes, LLC, Transmittal of Revision 2 of NWMI-2014-RPT-006, MCNP 6.1 Validations with Continuous Energy ENDF/B-VIL.1 Cross-Sections
Project stage: Request
ML17221A2012017-08-0505 August 2017
Attachment 3 to NWMI-2013-021, Rev. 2, Chapter 6.0 - Engineered Safety Features Construction Permit Application for Radioisotope Production Facility to Chapter 11.0 - Radiation Protection and Waste Management
Project stage: Request
ML17265A0462017-09-19019 September 2017
Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit
Project stage: Request
ML17265A0472017-09-19019 September 2017
Response to the U.S. Nuclear Regulatory Commission, Northwest Medical Isotopes, LLC - Request for Additional Information Regarding Preliminary Safety Analysis Report, Construction Permit Application
Project stage: Request
ML17262A1112017-09-21021 September 2017
Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit
Project stage: RAI
ML17283A1092017-09-28028 September 2017
Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit (TAC No. MF6138), Docket No. 50-609, Dated September 18, 2017
Project stage: Request
2016-05-18
[Table View] |
Text
May 24, 2016 Carolyn C. Haass Chief Operating Officer Northwest Medical Isotopes, LLC 815 Northwest 9th Street, Suite 256 Corvallis, OR 97330
SUBJECT:
NORTHWEST MEDICAL ISOTOPES, LLC - NOTICE OF HEARING, OPPORTUNITY TO PETITION FOR LEAVE TO INTERVENE, AND ORDER IMPOSING PROCEDURES REGARDING APPLICATION FOR CONSTRUCTION PERMIT (TAC NO. MF6138)
Dear Ms. Haass:
By letter dated February 5, 2015 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML15086A261), Northwest Medical Isotopes, LLC (NWMI) submitted part one, consisting primarily of its environmental report, of a two-part construction permit (CP) application for review by the U.S. Nuclear Regulatory Commission (NRC) under Title 10 of the Code of Federal Regulations (10 CFR), Part 50, Domestic Licensing of Production and Utilization Facilities. By letter dated July 20, 2015 (ADAMS Accession No. ML15210A182),
NWMI submitted the second of its two-part application for a CP.
By letter dated June 1, 2015, the NRC staff determined that part one of NWMIs application for a CP was complete and acceptable for docketing (ADAMS Accession No. ML15125A048). By letter dated December 24, 2015 (ADAMS Accession No. ML15341A112), the NRC staff informed NWMI that part two of its CP application for a production facility as defined in 10 CFR 50.2 Definitions, contained the remainder of the preliminary safety analysis report required by 10 CFR 50.34(a), was submitted in accordance with the requirements of 10 CFR 2.101(a)(5), and was placed, in its entirety, under Docket No. 50-609.
In accordance with the provisions of 10 CFR 2.104, a notice of hearing and opportunity to petition for leave to intervene on the application is being forwarded to the Federal Register for publication. Enclosed is a copy of that notice, including an order imposing procedures for access to sensitive unclassified non-safeguards information for contention preparation.
If you have any questions, please contact me at 301-415-2856 or by electronic mail at Michael.Balazik@nrc.gov.
Sincerely,
/RA/
Michael F. Balazik, Project Manager Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No. 50-609
Enclosure:
As stated cc: See next page
Pkg: ML16033A058; Letter: ML16033A180; FRN: ML16033A179 Memo to ADM: ML16033A185
- concurrence via e-mail ADM-012 OFFICE NRR/DPR/PRLB/PM NRR/DPR/PRLB/LA*
NRR/DPR/PRLB OGC NRR/DPR/PRLB NAME MBalazik NParker AAdams MBalazik DATE 2/24/16 2/19/16 4/11/16 4/28/16 5/24/16